Patent Number: 8,815,312

Title: Methods of use and nutritional compositions of Touchi Extract

Abstract: Disclosed is a method and composition for nutritional compositions containing glucosidase inhibitors, and more specifically Touchi Extract and its uses in the treatment of many disorders. These disorders include diabetes, hyperlipidemia, obesity, Metabolic syndrome/Syndrome X, COPD, malabsorption, Crohn's disease, diarrhea, constipation, irritable bowel syndrome, human immunodeficiency virus, cystic fibrosis, non-alcoholic steatohepatitis, polycystic ovarian syndrome including associate infertility, and erectile dysfunction. Further, glucosidase inhibitors, and more specifically Touchi Extract can be used to aid healing in critical care patients and for general wound healing. Additionally, glucosidase inhibitors, including Touchi Extract can be used to enhance athletic performance.

Inventors: Falk; Anne (Salt Lake City, UT), Roughead; Zamzam (Fariba) (Plymouth, MN), Miller; Kevin Burke (Minneapolis, MN), Jonnalagadda; Satya (Plymouth, MN), Greenberg; Norman Alan (New Hope, MN), Kaspar; Kala Marie (St. Louis Park, MN), Swanson; Julie (Minneapolis, MN)

Assignee: Nestec S.A.

International Classification: A61K 36/48 (20060101); A23F 5/00 (20060101); A61K 36/00 (20060101)

Expiration Date: 8/26/12018